期刊文献+

HPLC测定格列美脲顺式异构体的方法改进 被引量:5

Improvement of determination of cis-isomer in glimepiride by HPLC
原文传递
导出
摘要 目的:改进并建立测定格列美脲顺式异构体的高效液相色谱法。方法:采用二醇基硅胶色谱柱(250 mm×4.6 mm,5μm),以冰醋酸-正庚烷-无水乙醇(1∶900∶100)为流动相,流速1.0 mL·min-1,检测波长为228 nm。结果:在上述色谱条件下,格列美脲与顺式异构体分离度良好,顺式异构体的定量限为8 ng,在0.001~0.01 mg·mL-1范围内线性关系良好(r=0.9999)。顺式异构体相对于格列美脲的相对保留时间为0.9,校正因子为1.0。结论:可用不加校正因子的主成分自身对照法测定格列美脲中顺式异构体的含量。 Objective:To improve and establish a method for determining cis -isomer in glimepiride by HPLC. Methods:The determination was performed on a diol silica gel column (250mm×4.6mm,5μm) , and the mobile phase consisted of acetic acid - heptane - anhydrous ethanol( 1: 900: 100) at the flow rate of 1.0 mL . min-1. The detection wavelength was 228 nm. Results: An excellent separation was achieved for glimepiride and its cis - isomer under the above column conditions. The LOQ was 8 ng for cis - isomer, a good linearity was found in the range of 0. 001 -0. 01 mg. mL-1 (r = 0. 9999). The relative retention time between cis - isome and glimepiride was 0. 9 with a correction factor of 1.0. Conclusion: The method is suitable for the determination of cis - isomer in glimepiride as the self- calibration method for main component without adopting calibration factor.
出处 《药物分析杂志》 CAS CSCD 北大核心 2013年第1期150-153,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 格列美脲 抗糖尿病药 异构体 有关物质 杂质 高效液相色谱 方法改进 glimepiride antidiabetic isomer related substance impurity HPLC method improvement
  • 相关文献

参考文献6

二级参考文献11

共引文献25

同被引文献55

  • 1刘艳华,杨大伟,郭桂芳,梁先明,段文龙.兽药有关物质研究中的常见问题[J].中国兽药杂志,2012,46(8):49-52. 被引量:1
  • 2国家药典委员会编.中国药典[s].二部.北京:化学工业出版社.2010.附录14.472.
  • 3宋丽,廖洪利,谢静,臧志和.色谱法检测药物杂质的研究进展[J].西南军医,2007,9(5):79-80. 被引量:6
  • 4ICH. Impurities in new drug substances[ EB/OL]. http://www, ich. org/fileadmin/Public Web _ Site/lCH_ Products/Guidelines/Quality/Q3A_R2/Step4/Q3A_R2 Guideline. pdf , 2006-10-25/2014-09-06.
  • 5EP[S]. 8. Oth ed. 2013. 765-767, 3268-3269, 169-171, 1462- 1464, 1470-1471, 1459-1460, 1502-1503, 1482-1484, 1595- 1596, 1533-1535.
  • 6USP[S].37thed.2014.2504,2472,4048-4049.
  • 7Rao RN, Prasad KG, Naidu CG, et al. Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations[ Jl. Journal of Pharma- ceutical and Biomedical Analysis, 2011, 56 ( 3 ) : 471-478.
  • 8Durga Rao D, Kalyanaraman L, Sait SS, et al. A validated stability- indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form[J]. Journal of Pha~eutical and Biomedical Analysis, 2010, 52( 1) : 160-165.
  • 9Bertolini T, Vicentini L, Boschetti S, et al. A novel automated hy- drophilic interaction liquid chromatography method using diode-array detector/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceu- ticals[ J]. Journal of Chromatography A. 2014, 1365 : 131-139.
  • 10Kumar MN, Kumar KS, Kumar VJ, et al. Stability indicating ion chromatography method for the simultaneous determination of ibandr- onate sodium drug substance and its impurities[J]. Journal of Phar- maceutical and Biomedical Analysis, 2011, 54 ( 3 ) : 596-601.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部